Kesimpta 20 mg solution for injection in pre-filled syringe
COMB157G2410
Approved small_molecule active
Quick answer
Kesimpta 20 mg solution for injection in pre-filled syringe for Relapsing forms of Multiple Sclerosis (RMS) is a Approved program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Relapsing forms of Multiple Sclerosis (RMS)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active